Progesterone (P4) and estradiol (E2) modulate neurogenesis and synaptic remodeling in the hippocampus during the rat estrous cycle and in response to deafferenting lesions, but little is known about the steroidal regulation of hippocampal progesterone receptors associated with these processes. We examined the neuronal expression of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr), by in situ hybridization and immunohistochemistry. Pgr, a transcription factor, has been associated with synaptic remodeling and other major actions of P4, whereas Pgrmc1 is implicated in P4-dependent proliferation of adult neuroprogenitor cells and with rapid P4 effects on membranes. Ovariectomized adult rats were given E2, P4, or E2ϩP4 on two schedules: a 4-d model of the rodent estrous cycle and a 30-d model of postmenopausal hormone therapy. Pgr was hormonally responsive only in CA1 pyramidal neurons, and the induction of Pgr by E2 was partly antagonized by P4 only on the 30-d schedule. In CA3 pyramidal and dentate gyrus (DG) neurons, Pgr was largely unresponsive to all hormone treatments. In contrast to Pgr, Pgrmc1 was generally induced by E2 and/or P4 throughout the hippocampus in CA1, CA3, and DG neurons. In neuroprogenitor cells of the DG (immunopositive for bromodeoxyuridine and doublecortin), both Pgrmc1 and Pgr were detected. The differential regulation of hippocampal Pgrmc1 and Pgr by E2 and P4 may guide drug development in hormonal therapy for support of neurogenesis and synaptic regeneration. (Endocrinology 153: 759 -769, 2012) I nteractions of estradiol (E2) and progesterone (P4) drive reproductive organ remodeling during ovulatory cycles (1, 2). In anticipation of implantation, uterine cell growth is stimulated by blood elevations of E2 during the follicular phase. During the luteal phase in the absence of implantation, endometrial cell death (apoptosis) is promoted by the cyclic elevation and decrease of P4 (1, 2). Moreover, during rodent ovulatory cycles, there is cyclic synaptic remodeling in the hippocampus (3, 4), a brain region critical for memory. In the follicular phase, hippocampal CA1 pyramidal neurons grow additional dendritic spines and synapses, which then regress rapidly after ovulation when E2 falls and P4 rises (3-5). These ovarian-driven processes have been further resolved in ovariectomized (OVX) rats as independent actions of E2 and P4: after induction by E2 treatment, the decline of CA1 spines is dependent on the presence of elevated plasma P4 (4).
I
nteractions of estradiol (E2) and progesterone (P4) drive reproductive organ remodeling during ovulatory cycles (1, 2) . In anticipation of implantation, uterine cell growth is stimulated by blood elevations of E2 during the follicular phase. During the luteal phase in the absence of implantation, endometrial cell death (apoptosis) is promoted by the cyclic elevation and decrease of P4 (1, 2) . Moreover, during rodent ovulatory cycles, there is cyclic synaptic remodeling in the hippocampus (3, 4) , a brain region critical for memory. In the follicular phase, hippocampal CA1 pyramidal neurons grow additional dendritic spines and synapses, which then regress rapidly after ovulation when E2 falls and P4 rises (3) (4) (5) . These ovarian-driven processes have been further resolved in ovariectomized (OVX) rats as independent actions of E2 and P4: after induction by E2 treatment, the decline of CA1 spines is dependent on the presence of elevated plasma P4 (4) .
In these examples, E2 and P4 appear to act independently at different phases of cyclical remodeling processes. However, in several animal models, cotreatment with P4 attenuated E2-induced synaptic growth. In the OVX macaque, the induction by E2 of the synaptic proteins syntaxin, synaptophysin, and spinophilin in CA1 neurons was attenuated by coadministration of P4 (6) . Similarly, in the rat entorhinal cortex lesion model of Alzheimer disease, we showed that cotreatment with P4 attenuated E2-induced neurite outgrowth in the dentate gyrus (DG) (7) . In contrast to many examples of P4-E2 cross talk throughout the reproductive system, the proliferation of neural progenitor cells (NPC) derived from adult rat DG was induced by both E2 and P4, in vitro (8) and in vivo (9) . Because combined concurrent E2ϩP4 is commonly used for menopausal hormone therapy (HT) (10 -12) , we sought to clarify E2-P4 interactions in neuronal expression of Pgr, a transcription factor, and in progesterone receptor membrane component-1(Pgrmc1), a putative progesterone receptor (13, 14) . Both Pgr and Pgrmc1 have high-affinity P4 binding: Pgr, dissociation constant (K d ) ϭ 0.38 nM (15); Pgrmc1, K d ϭ 11 nM (16) .
Neuronal responses to P4 have been associated with both Pgrmc1 and Pgr. The decline of hippocampal CA1 spines by P4 in OVX rats described above was blocked by RU486, a specific antagonist of Pgr (4) . We also observed antagonism of neurite outgrowth by RU486 in an in vitro model (7) . However, Pgrmc1 mediated in vitro proliferation of rat NPC, in which Pgr was not detected (8) . Based on these findings, we hypothesized that Pgrmc1 will be more responsive than Pgr to ovarian steroids in DG neurons, whereas Pgr regulation will be more responsive in CA1 neurons than CA3 and DG neurons.
Pgrmc1 has been associated with diverse functions across the reproductive system that are less understood relative to Pgr. In rat ovarian granulosa cells, which lack Pgr, Pgrmc1 mediates the antiapoptotic effects of P4 (17) . Rapid membrane effects of P4 are also mediated by Pgrmc1, independently of Pgr, e.g. in the rapid P4-induced Ca 2ϩ influx of the acrosome reaction (18, 19) . Pgrmc1 sequences are associated with a remarkable variety of cell functions under yet other names (13, 20, 21) . During development, Pgrmc1 mediates neuronal guidance under the names: Vema (mouse) and VEM-1 (nematode) (22) . We verified that Vema and Pgrmc1 in GenBank share amino acid sequences. In adult rodents, Pgrmc1 was detected in the hippocampus, hypothalamus, and cerebellum (23, 24) . Both E2 and P4 induced Pgrmc1 in the sexually dimorphic nucleus of the preoptic area and the ventromedial nucleus of the hypothalamus (25) . However, these reports did not describe its cell level expression. We extend to the cellular level prior findings of steroid regulation of Pgrmc1 and Pgr. In whole hippocampal extracts and hypothalamic subregions, Pgr was induced by E2 (25, 26) . Whereas some studies have shown P4 antagonism of E2 induction of Pgr, the P4 antagonism may be only transient (27) . Moreover, in hypothalamus and posterior pituitary from chick embryos, P4 can induce Pgr (28) . Thus, P4 regulation of Pgr is physiologically complex and may vary widely between cell types. Less is known about Pgrmc1, which showed induction by both E2 and P4 in hypothalamic subregions (sexually dimorphic nucleus of the preoptic area and ventromedial nucleus) (25) . The hippocampal regulation of Pgrmc1and Pgr by E2 and P4 is undefined.
Two hormone treatment schedules were used: a 4-d model of rodent ovulatory cycles (4, 26, 29) and a 30-d model of the KEEPS trial of postmenopausal HT (10, 30) . We show differential regulation of Pgrmc1 and Pgr in hippocampal neurons by E2 and P4 and discuss the potential relevance to optimization of postmenopausal HT for maintaining cognitive functions (31) (32) (33) .
Materials and Methods

Animals and steroid replacement
Experiments conformed with standards of humane animal care in the National Institutes of Health Ethical Guidelines. Adult female Sprague Dawley rats (3 months old, 250 -300 g; nulliparous; 44 rats total Ϫ six rats per group for the 4-d replacement schedule and five rats per group for 30-d schedule) were used throughout. All animal procedures were performed under anesthesia with ketamine (80 mg/kg) plus xylazine (10 mg/kg). Experiments for the two hormone replacement schedules were run separately with different cohorts of animals. Nonetheless, the in situ hybridization (ISH) grain densities for both receptors in control OVX tissues were very similar in each experiment (Table 1) . (Fig. 1A) . Rats were bilaterally ovariectomized (OVX) 2 wk before hormone replacement and treated in four groups (n ϭ 6 per group): 1) Vehicle, 2) E2 alone, 3) P4 alone, and 4) E2ϩP4. The E2 alone and E2ϩP4 groups received two injections of E2 benzoate (10 g, sc in 100 l sesame oil) 24 h apart; other groups received only vehicle (100 l sesame oil) injections. On d 3, P4 alone and E2ϩP4 groups received P4 to simulate the luteal phase P4 elevation (single injection, 4 mg/kg, sc in 100 l sesame oil), the remaining two groups (E2 and vehicle) received vehicle injections. For evaluation of NPC, all groups were given a single injection of bromodeoxyuridine (BrdU) (100 mg/kg, ip) 1 h after last steroid injection, and killed 30 h after BrdU injection (Fig. 1A) .
Four-day replacement
Thirty-day replacement (Fig. 1B) . Fourteen (Fig. 1B) . Uterine weights showed expected doubling of wet weight in response to E2; the P4-only group was equivalent to OVX (data not shown). The 30-d hormone schedule with these implants yielded physiological levels of plasma E2 and P4 in our prior study (7) .
Tissue collection
After lethal anesthesia, rats were cardiac perfused with 0.9% saline, and brains were removed from the skull. One brain hemisphere was frozen on dry ice for ISH; the other was fixed in 4% paraformaldehyde, followed by sucrose cryoprotection (30% sucrose in 0.1 M phosphate buffer, pH 7.4) for immunohistochemistry (IHC).
Quantitative RT-PCR
Hippocampal tissue was obtained from intact female Sprague Dawley rats at defined stages of the estrous cycle (estrus; proestrus) and from OVX females. Total cellular RNA was extracted (Tri Reagent), and cDNA was prepared (2 ug RNA; Superscript III kit, Invitrogen, Carlsbad, CA). RT-PCR was performed with SYBR Green I and used the following primers: rPgrmc1 (forward, 5Ј-GCCTCAAGCCGCGTGACTTC-3Ј; reverse, 5Ј-CT GGGCAGGAGTGAGGTCAG-3Ј);rPgr(forward,5Ј-GTCAGT GGACAGATGCTA-3Ј; reverse, 5Ј-AGCTGTTTCACAAGA TCA-3Ј). Standard curves were constructed from serial dilutions of Pgrmc1 and Pgr plasmid controls and used the same primers.
ISH
Frozen brain hemispheres were sectioned sagitally (18-m) on a cryostat and stored at Ϫ80 C until use. For ISH, [ 35 S]UTPlabeled sense-and antisense riboprobes were generated by in vitro transcription using 1 g linearized plasmid from the following sequences: for Pgrmc1, nucleotides 1012-1374 of rat Pgrmc1 mRNA (34); for Pgr, nucleotides 1-548 of the steroidbinding domain of both rat progesterone receptor isoforms (PR-A and PR-B) [kindly provided by Dr. S.L. Petersen (35) ]. Both Pgrmc1 and Pgr cRNA probes had the same specific activity (4.9 ϫ 10 6 cpm/l) and concentration in hybridization buffer (0.3 ng/l/kb). Labeled probe (1 ng) was used per slide and hybridized at 55 C. Posthybridization washes were performed in 50% formamide/2 ϫ saline-sodium citrate (SSC), 0.5 ϫ SSC, and 0.1 ϫ SSC at 60 C. Slides were then dehydrated in graded 0.3 M ammonium acetate-alcohol series and exposed to x-ray film for 
Pgrmc1 and Pgr grain densities after hormone treatment. Emulsion-dipped slides for Pgrmc1 and Pgr were exposed for different times to achieve similar grain densities. Statistical comparisons were made within treatment groups for each receptor. 
Antibodies
Primary antibodies used were: polyclonal rabbit anti-Pgrmc1 (1:300, HPA002877, Sigma-Aldrich, St. Louis, MO); polyclonal rabbit anti-Pgr (1:50, sc-538, Santa Cruz Biotechnology, Inc., Santa Cruz, CA); polyclonal goat anti-doublecortin (1:100, sc-8066, Santa Cruz Biotechnology; Refs. 37 and 38); monoclonal rat anti-BrdU (1:100, MCA2060, AbDSerotec, Raleigh, NC; Refs. 39 -41) . Secondary antibodies used were goat antirabbit biotinylated antibody (1:200, Vector Laboratories,), goat antirat conjugated to Alexa Fluor 594 (1:400, Molecular Probes, Inc., Eugene, OR; Invitrogen), donkey antigoat conjugated to Alexa Fluor 594 (1:400, Molecular Probes, Invitrogen). The specificity of the Pgrmc1 antibody was confirmed by Western blotting of rat whole hippocampal and cortical lysates. Two bands were detected, a strong band at 25 kDa and a weak band at 50 kDa corresponding to Pgrmc1 monomer and dimmer, respectively (42, 43) . The Santa Cruz Pgr antibody detected both PR-A and B isoforms. Western blot bands corresponded to PR-A and B at approximately 95 kDa and 110 kDa (Supplemental Fig. 7A ). Specificity of the antibody was confirmed by preadsorbing the antibody with 10-fold excess of immunizing peptide (sc-538P, Santa Cruz Biotechnology), which depleted the Pgr bands on Western blots (Supplemental Fig. 7B ) and parikaryal staining after IHC (Supplemental Fig. 7, C and D) . We did not detect cellular staining with the rabbit PR antibody (1:100, A0098, DAKO Corp., Carpinteria, CA) in adult rat hippocampus, confirming the results of Waters et al. (44) .
Immunohistochemistry (IHC)
Perfused brain hemispheres were fixed in 4% paraformaldehyde at 4 C for 24 h followed by cryoprotection in 30% sucrose/PB before sagittal sectioning as above. IHC was performed on whole hemisphere sagittal sections according to Morgan et al. (36) , and the dorsal hippocampus was analyzed. Briefly, sections were fixed in 4% paraformaldehyde and permeabilized in 1% Nonidet P-40, followed by blocking in 5% normal serum. Sections were then incubated in primary antibodies overnight at room temperature
Data analysis
Data are shown as means Ϯ SEM. Grain densities in Fig. 3 were calculated as the percentage of OVX controls. Statistical comparisons are based on ANOVA followed by Fisher post hoc analysis, with significance at P Ͻ 0.05.
Results
Distribution of progesterone receptors in hippocampal subregions
First, we determined the relative prevalence of Pgrmc1 and Pgr mRNA in whole hippocampus. By RT-PCR, Pgrmc1 mRNA prevalence was 4-fold above Pgr mRNA in OVX rats. At proestrus and estrus stages, Pgrmc1 was 2-fold above Pgr (Supplemental Fig. 8 ). The ISH exposure times to reach equivalent grain density differed correspondingly for cRNA probes of the same concentration and specific activity (see Materials and Methods). Hippocampal regions differed in neuronal expression of Pgrmc1 and Pgr. Pgrmc1 mRNA per cell was 2-fold higher in CA1 and CA3 pyramidal neurons than in DG neurons (Fig. 2, A and B, and Table 1 ). However, CA1 and CA3 neurons had similar levels of Pgrmc1 mRNA. Within hippocampal regions, neuronal Pgr mRNA prevalence was highest in CA3, followed by CA1 and DG, in ratios of 4:2:1 (Fig. 2, A and B, and Table 1 ). These regional differences in Pgrmc1 and Pgr expression extend semiquantitative analyses of Intlekofer and Petersen (23) .
A minority of DG neurons expressed Pgr mRNA (27 Ϯ 4.2% cells had Ն2 grains per cell for Pgr), whereas, Pgrmc1 was detected in most DG neurons (82 Ϯ 5.1% cells had Ն2 grains per cell; P Ͻ 0.0001) (Fig. 2B) . Thus, 3-fold more DG neurons had significant signal for Pgrmc1 than for Pgr, in contrast to CA1 and CA3 pyramidal neurons, in which both receptors were detected in more than 80% neurons (Fig. 2B) .
Immunostaining for cell body protein levels of Pgrmc1 and Pgr (Fig. 2C ) corresponded to RNA levels by ISH grain densities ( Fig. 2A) . Again, Pgr protein was detected in a minority of DG neurons. A caveat is that protein levels of Pgrmc1 and Pgr cannot be directly compared due to the different techniques used to visualize the signals from both receptors (Methods; Pgr detection required two rounds of signal amplification, whereas Pgrmc1 did not require amplification). Whereas Pgrmc1 immunostaining had similar intensity throughout the hippocampal cell layers (Fig. 2C) , Pgr immunostaining was stronger in CA3 than in CA1 and DG neurons (Fig. 2C ).
E2 and P4 differentially regulate Pgrmc1 and Pgr mRNA in hippocampal subregions
Two schedules of steroid replacements (E2, P4, and E2ϩP4) of OVX young rats were compared: a 4-d model
FIG. 2. Expression of Pgrmc1
and Pgr in hippocampal neuronal layers. A, Autoradiographic film images showed differential distribution of mRNA for Pgrmc1 (left) and Pgr (right) in hippocampal neuronal layers. Pgrmc1 was prevalent across all three neuronal layers. By contrast, Pgr mRNA was prevalent in CA1 and CA3 pyramidal neurons, but it was barely detected in adjacent DG neurons. B, Average grain density for Pgrmc1 and Pgr in individual neurons of CA1 (100 cells per rat), CA3 (100 cells per rat), and DG (120 cells per rat). Pgrmc1 grain density was similar in CA1 and CA3 neuronal perikarya and far below in DG neurons. *, P Ͻ 0.01 vs. CA1 and CA3. More than 80% neurons in CA1, CA3, and DG were positive for Pgrmc1 mRNA. CA3 neurons had 2-fold more Pgr mRNA/perikaryon than CA1 and DG neurons. CA1 neurons had 2-fold Pgr over DG neurons. More than 80% CA1 and CA3 neurons, but only approximately 25% DG neurons were positive for Pgr mRNA. **, P Ͻ 0.0001 vs. other groups. C, Immunohistochemistry for Pgrmc1 and Pgr showed similar protein expression of both receptors as mRNA. Scale bars, 100 m. Avg., Average. (Fig. 1) . By ISH, Pgrmc1 mRNA was broadly induced above OVX controls by 44 -92% with E2 and/or P4 on both schedules in all neuronal layers of the hippocampus (Fig. 3A and Table 1 ). In contrast, Pgr induction was regionally restricted on both hormone schedules. Pgr was induced only in CA1 neurons, with minimal response in CA3 and DG neurons ( Fig. 3B and Table  1 ). All steroid treatments in the 4-d schedule induced Pgr mRNA by at least 50% in CA1 neurons. However, the 30-d schedule showed more modest effects, with Pgr induction in CA1 only by E2 or P4 alone (ϳ35%, P Ͻ 0.05). The absence of induction by E2ϩP4 suggests antagonism. In CA3 neurons, only the 4-d schedule induced Pgr mRNA, and very modestly (22% by P4, P Ͻ 0.05; 24% by E2ϩP4, P Ͻ 0.04; no response to E2 alone), whereas the 30-d schedule had no effect. Moreover, Pgr in DG neurons was unresponsive to all hormone schedules.
Progesterone receptor expression in NPC
Because of conflicting reports on the expression of Pgr in NPC (see Introduction), we evaluated Pgrmc1 and Pgr expression in the endogenous NPC of the DG subgranular zone. Double IHC colocalized both Pgrmc1 and Pgr in more than 90% of the BrdU-labeled progenitor cells (Fig. 4, A and B) . Furthermore, the Doublecortin marker for NPC destined to be neurons also colocalized with both Pgrmc1 and Pgr (Fig.  4, C and D) . The 4-d steroid treatments increased BrdU-labeled cells in the DG subgranular zone by 50 -100% (Fig.  4E) , consistent with the findings of Liu et al. (9) . Separately, E2 or P4 treatment doubled the number of proliferating NPC (P Ͻ 0.03), wherease the combination of E2ϩ P4 was not significant (Fig. 4E ).
Discussion
We show that Pgrmc1 and Pgr differ markedly in expression and in regulation by E2 and P4 in neurons of the adult rat hippocampus, and discuss implications for hormonal regulation of synaptic plasticity and NPC proliferation. Overall, Pgrmc1 was widely expressed throughout hippocampal neurons and was induced by both E2 and P4. In contrast, Pgr showed limited expression and regulation by steroids that differed widely among neuronal subpopulations. In those responding neurons, both acute and chronic E2 and P4 replacements gave equivalent induction of Pgrmc1 and Pgr, with little or no mutual antagonism. We hypothesize that Pgrmc1 and Pgr mediate selective hippocampal P4 effects in different neuron subtypes based on their different regional expressionandresponsestoE2andP4.Thesefindingsarerelevant to cognitive functions in postmenopausal HT.
Differential expression of Pgrmc1 and Pgr in hippocampal subregions
First we discuss the neuroanatomical differences in expression of these receptors in the hippocampus, a key site of learning and memory. Pgrmc1 was equally prevalent in CA1 and CA3 neurons, with lower expression in DG neurons. Pgr, on the other hand, was most prevalent in CA3 neurons and much less in DG neurons. microscopy, Waters et al. (44) localized extranuclear Pgr in axons of hippocampal neurons, with greater detection in CA3 axons than in other hippocampal neurons. However, detection of Pgr protein by immunohistochemistry required secondary signal amplification in the present study. We confirmed the neuronal cell type-restricted expression of Pgr by RNA and protein content (in situ hybridization and immunohistochemistry, respectively). In contrast, Pgrmc1 was expressed throughout the hippocampal neuron layers. Expression in the hippocampal hilus of Pgrmc1 and Pgr (Fig. 2C ) could represent interneurons, as well as glia. Although this study was focused on Pgrmc1 and Pgr expression in different hippocampal neurons, we also observed glial expression of both receptors both in vivo, and in cultured primary glia (data not shown; our unpublished results, Bali N., T. E. Morgan, C. E. Finch).
Differential regulation of Pgrmc1 and Pgr mRNA
In addition to the regional differences in levels of expression between hippocampal neuron types, both We have used this 30-d replacement schedule to show P4 antagonism of E2-dependent synaptic sprouting in response to deafferenting lesions of the hippocampus (7). Clinical trials for postmenopausal HT for age-associated cognitive decline and Alzheimer disease are controversial. The Women's Health Initiative study, one of the largest randomized controlled clinical trial of HT, found increased breast cancer incidence in the group receiving equine estrogens plus a progestin, and no cognitive benefits (11, 12) . Thus, it is imperative to study the combined effects of E2 and P4 on cognition, cardiovascular disease, and other health outcomes. The KEEPS trial addresses the effects of delayed initiation of HT (critical window hypothesis); KEEPS also evaluates cyclic vs. continuous P4. In a triple transgenic mouse model of Alzheimer disease, three consecutive 30-d cycles of E2 and P4 (present model) were neuroprotective (30) . Most animal models of longterm HT have evaluated E2 alone (46 -48) . The present studies also used a 30-d hormone schedule, as well as a 4-d schedule to model the normal estrous cycle. On both the 4-and 30-d replacement schedules, Pgr was induced by both E2 and P4, but only in CA1 neurons and not in CA3 or DG neurons. In contrast, Pgrmc1 was more broadly responsive to E2 and P4, across all neurons examined. About 40 -80% induction was seen after both 4-and 30-d schedules, with similar responses in the CA1, CA3, and DG neurons. The similar induction in CA1 neurons of both Pgrmc1 and Pgr by E2 and P4 is relevant to synaptic remodeling. CA1 neurons are notable for synaptic remodeling during the rodent estrous cycle, not observed in CA3 or DG neurons (Introduction). Moreover, in OVX macaques, E2 replacement for 28 d alone induced synaptogenesis in CA1 neurons (6) . Introduction of P4 to the last 14 d of E2 treatment antagonized the E2-mediated increase in pre-and postsynaptic proteins, syntaxin, synaptophysin, and spinophilin, whereas P4 alone treatment increased synaptophysin in CA1 neurons. This report gives an unusual example in which P4 alone can induce synaptic proteins and with mutual antagonism of E2ϩP4. We found similar responses of Pgr in CA1 neurons during the 30-d schedule. However, on a 4-d schedule, there was no indication of mutual antagonism. The differences in P4 actions when acting alone vs. E2ϩ P4 on a 30-d schedule are relevant to HT strategies.
The equal induction of Pgrmc1 and Pgr by E2 and P4 raises interesting questions about transcriptional regulation, particularly their autoinduction by P4. We did not find full consensus progesterone response elements (PRE) in the Pgr gene. However, Pgr has multiple half-PRE sites, which, in other genes, can bind the Pgr peptides in synergy with other cofactors (49, 50) . The autoinduction by P4 is consistent with the elevation of Pgr protein in the hypothalamus during pregnancy, which peaks at d 19 of rat pregnancy when plasma P4 is maximal, with much lower E2 (51) . The transcriptional regulation of Pgrmc1 has not been studied. We did not find consensus PRE in the Pgrmc1 upstream promoter, but did find multiple half-PRE sites. Thus, the P4 autoinduction of Pgrmc1 observed in the hippocampus here and in the hypothalamus (25) could be mediated indirectly by Pgr through binding of Pgr peptides to half-PRE sites.
The observed E2 regulation of Pgrmc1 and Pgr could be mediated by estrogen receptors (ER). We can dismiss a mechanism of cross talk at the ligand-binding level, because E2 does not compete with P4 for binding to either Pgrmc1 (16) or Pgr (53); nor does P4 compete with E2 at physiological levels for binding to ER (54) . The Pgr promoter contains multiple ERE (estrogen response element) sequences that could mediate induction by E2 (55, 56, 57) . Although we did not find consensus ERE in the Pgrmc1 upstream promoter, there are multiple half-ERE sites. Both ER␣ and ER␤ are expressed in hippocampal neurons (58 -60) , though ER␤ was more prevalent in CA1 and CA3 pyramidal neurons than in DG neurons (59, 60) , resembling the expression of Pgrmc1 and Pgr (Fig. 2) . The importance of Er␣ to Pgr regulation is shown by the absence of induction by E2 in the hippocampus of ERKO␣ mice (61) .
The pharmacological specificity of Pgrmc1 and Pgr also needs further study. The antiprogestin RU486 blocked the decrease in CA1 dendritic spines during the estrus (4) and also blocked P4 antagonism of E2-induced neurite outgrowth in an in vitro lesion model (7) . Although RU486 does act on recombinant Pgr (62, 63) , it is not known whether it also acts on Pgrmc1. In addition to Pgrmc1, three other membrane PR are recognized: the G protein-coupled receptors mPR␣, mPR␤, and mPR␥. Little is known of their expression patterns in brain cell types, P4 binding characteristics, and steroidal regulation, or P4-specific functions (23, 25, 64 -67) .
CA1 neurons were the only hippocampal subregion that showed similar hormonal responses of both Pgrmc1 and Pgr (Fig. 3) . This regional restriction is interesting because CA1 neurons are more vulnerable to Alzheimer disease (68, 69) , postischemic damage (70) . and hypoxiainduced seizure activity, relative to CA3 and DG neurons (71) . The responsiveness of progesterone receptors to E2 and P4 is relevant to stroke because CA1 neurons are protected in rodent models of ischemia by both E2 (72, 73) and P4 (74) . The P4 neuroprotection of CA1 could be mediated by either Pgrmc1 or Pgr. The receptor involved in CA1 neuroprotection could be identified using Pgr knockout mice (PRKO). However, Pgrmc1 knockout mice have not been reported so far.
Pgrmc1 and Pgr expression in NPC of the subgranular zone of DG
The DG was examined for expression of Pgrmc1 and Pgr in its P4-sensitive NPC, which have not been characterized in detail. In adult female rats (9) and male mice (75) , P4 promoted the generation of nascent neurons in the DG subgranular zone. Both E2 and P4 stimulated NPC proliferation in cells obtained by whole hippocampus cell sorting (9) and in an established adult rat NPC line derived from the DG subgranular zone (8, 76) , as confirmed in vivo here. The in vitro proliferative effects of P4 involve Pgrmc1 through P4-induced kinase signaling (8) . The present study detected both Pgrmc1 and Pgr in newly formed immature neurons (Doublecortin immunopositive) in the subgranular zone. However, most DG mature neurons lack Pgr (Fig. 2B) , which may be consequent to DG neuronal maturation, e.g. Pgr expression in the DG peaked by postnatal d 7 and was undetectable by d 28 (77, 78) . Lastly, we note the divergence in Pgr expression between NPC lines. Whereas a rat NPC line derived from the DG subgranular zone did not have Pgr by PCR (8), Pgr protein was detected in NPC originated from the subventricular zone, another site of adult neurogenesis (52) . This difference could be outcomes of continued in vitro propagation of the DG subgranular cell line or to the different sites of NPC origination.
The responses of Pgrmc1 and Pgr to P4 Ϯ E2 were very similar for both 4-d and 30-d hormone replacement schedules. Pgrmc1 was increased in all hippocampal neuronal layers on both schedules in which E2 alone, P4 alone, or combined gave similar induction. Whereas Pgr responses were restricted to CA1 neurons, responses to E2 and P4 alone or together were again equivalent on the 4-d schedule. However, the weaker increase of Pgr in CA1 on the 30-d schedule of combined E2ϩP4 suggests possible antagonism. Others have reported selective induction. In the hypothalamus (25) only select nuclei showed Pgrmc1 elevations with P4 alone or E2ϩP4; unlike hippocampal responses, there was no effect of E2 alone. In contrast, Pgrmc1 (cited as 25-Dx) was increased in the hypothalamus of E2-primed OVX females, but this increase was attenuated by P4 (34) . Reports on Pgr are also divergent. As we observed in CA1 neurons with both hormone schedules, P4 alone increased Pgr in chick embryo hypothalamus and posterior pituitary (28) . However, Intlekofer and Petersen (25) observed that P4 alone did not increase hypothalamic Pgr mRNA. A more detailed study of the time course is warranted because Turgeon et al. (27) showed the transiency of P4 down-regulation of Pgr, with receptor levels returning to the level of E2-treated controls by 12 h after treatment.
Conclusions
Pgrmc1 is widely expressed in neuronal layers of all hippocampal regions and is induced by both E2 and P4. In contrast, Pgr shows restricted regional expression and regulation by E2 and P4. The shared induction of both Pgrmc1 and Pgr by E2-P4 in CA1 neurons may be relevant to their capacity for E2-dependent synaptic remodeling and to CA1 sensitivity to neurodegeneration from Alzheimer disease and ischemia. The differential regulation of hippocampal Pgrmc1 and Pgr gives a rationale for development of drugs in hormonal therapy to target multiple receptors in the support of neurogenesis, neuroprotection, and synaptic regeneration.
